Find Resources and Support - National Multiple Sclerosis Society

Skip to navigation Skip to content

Find Resources and Support

The Society offers many programs and services to help people affected by MS live their best lives. Find resources in your area to learn, connect, and get support.

  1. Research

    Emerging Therapies Collaborative

    The Multiple Sclerosis Emerging Therapies Collaborative has been organized to provide timely, evidence-based resources regarding the known benefits and risks of newly emerging, FDA-approved medications for MS. This group, which includes the MS Coalition, the American Academy of Neurology, the Multiple Sclerosis VA Centers of Excellence East and West, Can Do MS, Consortium of MS Centers, International Organization of MS Nurses, MS Association of America, MS Foundation, National MS Society, Unit

  2. Research

    MS Clinical Care Connection

    MS Clinical Care Connection - the Society's quarterly newsletter for healthcare professionals - delivers information and resources on a variety of clinical topics.

  3. IN PERSON Clinical Trials


    A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects with Relapsing Forms of Multiple Sclerosis When Used Concurrently with Avonex® (215MS201, SYNERGY)

    St. Louis, MO 63110See Map
  4. IN PERSON Clinical Trials

    215MS301, ALLOW

    An Open-Label, Two-Arm, Randomized Study to Characterize Flu-Like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning from Current Interferon Beta Therapies to BIIB017 (215MS301, ALLOW)

    St. Louis, MO 63110See Map
  5. IN PERSON Clinical Trials


    A 12 month, dose-blinded study that compares the safety and effectiveness of 0.25 and 0.5 mg daily oral fingolimod with daily subcutaneous injection of 20 mg glatiramer acetate (Copaxone) in patients with Relapsing Remitting MS.

    St. Louis, MO 63017See Map
  6. IN PERSON Clinical Trials


    A study to describe efficacy, tolerability and convenience of teriflunomide (Aubagio) treatment using PROs (Patient Reported Outcomes) in RMS (Relapsing MS) patients.

    St. Louis, MO 63017See Map
  7. IN PERSON Clinical Trials

    ASSESS MS Study: FTY720D2312

    A 12-month, randomized, rater-and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis.

  8. IN PERSON Clinical Trials

    Aubagio® Patient Reported Outcomes

    This research study will collect data on patient satisfaction related to the oral drug, Teriflunomide (Aubagio®) at five specified time points over the first year of treatment. Aubagio® will be provided to patients participating in the study.

  9. IN PERSON Clinical Trials

    Donate Blood for Research

    Study to identify genes important in MS development (Dr. Laura Piccio and Dr. Anne Cross).

  10. IN PERSON Clinical Trials

    A Trial of Vitamin D and Copaxone in Patients with Relapsing MS

    This research study will evaluate whether Vitamin D when given with Copaxone reduces the rate of relapse in 2 years. Eligible Participants will be randomized to receive either low dose or high dose vitamin D (oral) with Copaxone. Copaxone and Vitamin D are provided as part of the study.